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1. Introduction
Human leukocyte antigen (HLA) complex, which refers to a group of closely linked genes on
the short arm of the sixth human chromosome, is considered the most polymorphic genetic
marker that has so far been reported in the human. HLA plays a significant role in the immune
response, particularly in antiviral immunity. Although HLA and genetic predisposition to
various autoimmune diseases have been separately studied for the past 40 years, the evaluation
of the correlation between the two was initiated only within the last 10 years. In recent years,
research on HLA polymorphisms and susceptibility to various infectious diseases has attracted
significant attention owing to the critical role of HLA in diseases such as SARS and hepatitis
B. In particular, HLA polymorphism, HIV, and genetic predisposition to AIDS have emerged
as research areas of immense clinical significance.
Human immunodeficiency virus (HIV) infection is able to perturb and alter gene expression
through several mechanisms that can, lastly, cause acquired immunodeficiency syndrome
(AIDS) Figure 1. Meanwhile, associations between disease parameters and the genetic makeup
of the host and virus may be crucial in determining the outcome of HIV-1 infection.
According to Joint United Nations Programme on HIV/AIDS, there were approximately 40
million HIV-infected people worldwide at the end of 2004. Limiting the susceptibility to HIV,
predicting the course of AIDS, and reversing it are some of the challenging tasks that need to
be addressed urgently. Existing data demonstrates that the susceptibility to HIV differs among
individuals, and significant differences exist in the disease progression in HIV-infected
persons. In general, it takes less than 10 years from the time of HIV infection to the manifes‐
tation of typical AIDS symptoms. However, a small subset of HIV-infected people (0.8%) are
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asymptomatic for over 10 years. According to a number of studies, the HLA complex is
considered as the most noteworthy genetic marker that is closely related to AIDS progression
and highlights the differences in genetic susceptibility of HIV-infected individuals.
2. HLA polymorphism and genetic predisposition to HIV
1. Epidemiological survey: Worldwide epidemiological surveys indicate that there is a close
relationship between HIV/AIDS and HLA. Although global research reports at different
times have demonstrated the involvement of HLA in the differential susceptibility to HIV,
the individual HLA locus has not been validated to correlate with HIV infection or AIDS
progression. For example, some reports indicate a correlation between HIV susceptibility
Figure 1. HIV virus is formed by a diploid single strand RNA genome enclosed in a truncated cone capsid with a phos‐
pholipidic bilayer envelope, containing the proteins that allow the virus entry into the cells. The HIV-1 infection is
mediated by interaction between the proteins of the viral envelope, leukocyte receptor, and coreceptor. This interac‐
tion causes the membranes fusion and the uncoating of the virion core. The viral RNA is reverse transcribed in DNA
which enters in the nucleus where the integrase enzyme catalyzes the insertion of the viral genome into the genome
of the host cell. The expression of integrated viral genome is controlled by the RNA-binding proteins tat and rev. A set
of RNAs are transported from the nucleus to the cytoplasm, where they can be translated or packaged. The new core
proteins localize near the cell membrane, while the envelope mRNA is translated at the endoplasmic reticulum (ER)
and subsequently the envelope proteins are placed on the cell membrane. Finally, the capsid proteins are assembled
with the viral genomic RNA, and an immature virion begins to bud from cell surface.
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and HLA-B*35 in ethnic groups of Han. However, findings of research on Caucasian
individuals did not agree with this notion. HLA-B*07, found among people of African
descent, is considered to correlate with the susceptibility to HIV, but the similar correlation
has not been reported among people of other ethnic groups. Research on other ethnic
groups indicates that HLA-B*18 and the HLA-A2 either influence HIV-1 infectivity or act
as protective genes that inhibit the incidence of AIDS. The homozygous HLA-G 14-bp
nsertion/deletion genotype is associated with higher viral load, lower CD4 cell count, and
increased mortality compared with HLA-G 14-bp carriers.
Considering the limitation of the small population evaluated, polymorphisms outside the
peptide binding region of the HLA class I molecule can play a key role in HIV progression
through interaction with other immune-relevant receptors. Some results identify co-operative
effects between HLA Class I alleles in the control of HIV-1 in an extended Southern African
cohort, and underline complementarity and breadth of the CD8+ T cell targeting as one
potential mechanism for this effect. HLA-A-restricted Gag-specific responses can impose
selection pressure on HIV. Vaidya et al analyzed the associations between HLA-B alleles and
HIV-1 viral replication during acute infection and VLSP in untreated subjects. The results show
that the effect of HLA-B*57 on viral control is more pronounced during the later stages of
primary HIV-1 infection, while HLA-B*97 is more broadly associated with HIV-1 viral load
during primary infection. In HIC (HIV controllers, a unique group of infected individuals who
are able to control HIV naturally), HLA-B*57 and the amount of ultrasensitive viral load seem
to play a role in the HIV-specific CD8+ T cell responses. Some results provide support for the
role of HLA-B*51-restricted CTLs and functional avidity in the control of early HIV-1 infection.
HALS (HIV/Highly active antiretroviral therapy-associated lipodystrophy syndrome) is
associated with combined low-expression TS (thymidylate synthase) and MTHFR (methylene-
tetrahydrofolate reductase) associated with high activity polymorphisms but not with HLA-
B*40:01 carriage in Caucasian patients with long-term exposure to stavudine. For details, see
Table 1.
Richard et al characterized the differential cell surface expression levels of all common HLA-
C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection
in 5243 individuals. They found that HIV peptides presented by higher expressed HLA-C
alleles were more likely to elicit CTL responses than peptides presented by low expression
HLA-C allotypes, such that higher HLA-C expression was correlated with increased likelihood
of cytotoxic T lymphocyte responses and frequency of viral escape mutation. It is also pointed
out that HLA-C and HLA-E collaborate to keep the HIV-1 virus at bay. HLA-C can present
antigens to CTL, and it is able to inhibit NK cell lysis, but for some reason it is normally
expressed on the cell surface at levels approximately 10-fold less than most HLA-A and HLA-
B allotypes. The mechanisms that regulate HLA-C expression and the link between this
molecule and HIV infection are not yet completely understood. Maybe a new miRNA targeting
sequences identified on HLA-C gene and the low level of affinity between β2M and the HLA-
C heavy chains can explain for this low level of expression.
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Cohorts used in study
HLA locus or haplotype or supertype
Susceptible to HIV or AIDS FP Non-susceptible to HIV or AIDS SP
Han Ethnicity B*35 -
Zambian A*02-Cw*16, A*23-B*14, A*23-Cw*07(FP) B*57, B*39, A*30-Cw*03(SP)
European A1-Cw7-B8-DR3, A24(FP) -
Yi Ethnicity B*07, B*35, B*46 B*55, B*44, B*78
Kenya A*29, Cw*07, Cw*08 (HT) B*18(LT)
Kenya A*2301 A2/6802 supertype(LT)
Argentina A*24, B*18, B*39 B*44, B*55
African-American DQB1*0201 DQB1*0303
Caucasian DQB1*0603, DRB1*04 DQB1*0303
European A*29, B*22, DR*11(FP) B*14, Cw*08(SP)
Caucasian Heterozygous HLA locus, Type I B*35, Cw*04
American B*54, B*55, B*56 -
American - B*18(LT)
Male Caucasian
Homosexuals B*35 A2 supertype
Zimbabwean HLA-G 14-bp insertion/deletion
European-American HLA-C low expression HLA-C high expression
FP, fast progression; SP, slow progression; HT, high transmission; LT, low transmission
Table 1. HLA genes, haplotype, and supertype related to HIV-1 susceptibility and AIDS progression
2. In vitro study on HLA and HIV infection susceptibility: It is difficult to extrapolate the
common characteristics from the results of epidemiological surveys owing to the abun‐
dance of inherent variation. Some researchers try to analyze HLA and HIV infection
susceptibility by using in vitro approaches, and speculate the relationship between HLA
polymorphism and HIV infection susceptibility or AIDS progression. In vitro studies can
better control significant influencing factors such as the type, developmental stage and
culturing conditions of cells, type of HIV strain, density of infection, and mechanisms, as
well as minimize the variable factors that will have an effect on statistical findings. Second,
in vitro experiments facilitate the consistent evaluation of critical factors as well as the
application of uniform testing standards.
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Jabri and his colleagues used two strains of HIV-1 and HIV-2 to infect peripheral blood cells
with different HLA antigenic specificities, and reported that no single HLA antigen was
capable of preventing both types of HIV infection. For example, HLA-B52 showed suscepti‐
bility to HIV-1 viral strains, whereas it was not susceptible to HIV-2 viral strains. HLA-B58
showed susceptibility to HIV-2 viral strains, but it was not susceptible to HIV-1 viral strains.
HLA-B44 influenced the immune function only against certain HIV-1/2 strains. It is still
therefore still ambiguous whether different HLA phenotypes influence the susceptibility to
and in vivo effects of HIV infection, which needs to be verified by experiments with larger
sample sizes.
HLA-G variant expression has a considerable impact on the control of HIV replication, an effect
that seems to be mediated primarily by the protein specificity of CD4(+) T cell responses to
HIV Gag and Nef. Numerous studies have been conducted, aimed at observing the expression
of the molecule HLA-G in the early stage of infection by HIV and its progression. In 2004,
Derrien and colleagues demonstrated that during HIV-1 infection the HLA-G1 isoform was
down regulated by a Vpu dependent mechanism, which recognizes a double lysine residues
in 4 and 5 positions of the C terminus. The HLA-G1 isoform has the major ability to present
viral peptides to CD8+ T lymphocytes; therefore, the recognition of HIV-1 infected cells by
CD8+ T lymphocytes could depend on the expression of HLA-G1.More results show that HLA-
G Treg plays an important role for balancing by stander immune activation and anti-viral
immune activity in HIV-1 infection and suggest that the loss of these cells during advanced
HIV-1 infection may contribute to immune dysregulation and HIV-1 disease progression. The
connection between miRNA, HLA-G expression, and HIV-1 also needs to be further explored
because it can reveal novel information about HIV-1 control of the immune system.
3. Statistical analysis of the correlation between HLA gene polymorphism and HIV infection
or AIDS susceptibility: Previously published research findings have been analyzed to
evaluate the diversity in the correlation of HLA with HIV/AIDS susceptibility. Meta-
analysis was anticipated to identify the common features. Research articles that satisfy
the selection criteria were retrieved and the original data in the documents were processed
and analyzed, wherein B35, B62, DR5, and DR11 were identified as genes that facilitate
HIV-1 susceptibility and/or occurrence of AIDS, while A10, B18, B27, B5, and DR1 were
identified as protective genes against HIV-1 infection and/or occurrence of AIDS. Since
meta-analysis is an observational study, variations are likely to be introduced in each step
of the analysis, and the results need to be validated by testing in laboratories with a large
sample size.
3. Possible mechanisms that HLA influence HIV infection susceptibility or
AIDS progression
1. Infection receptors: HIV combines with the CD4 molecule and other coreceptors to invade
T cells during infection. HIV susceptibility is affected when the above-mentioned
receptors have natural defects or mutations. So far, it has been verified that receptors of
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chemotactic factors (CCR35 and CXCR4) are coreceptors for HIV-1. When HIV-1 infects
target cells, the viruses that combine with CD4 molecules combine with coreceptors in
order to enter the target cells. In high-risk populations with close contact to infected
individuals but no infection, approximately one-third of the CCR5 alleles undergo
deletion mutation; for instance, deletion of 32 bases of CCR5 genes (referred to as
CCR5Δ32 mutation), which results in a natural immunity of the organism against HIV-1
infection at the gene level. The mutation and polymorphism changes of alleles not only
influence the ability of HIV-1 to infect the target cells, but also change the onset and
progression of AIDS. It is possible that HLA participates in HIV invading process through
similar means, and affects AIDS progression. However, there are no validated reports on
HLA’s direct participation in HIV-1 infection by acting as the receptor, so far. Therefore,
the susceptibility theory, which suggests that HLA acts as a receptor, needs to be subjected
to further scientific scrutiny.
2. HLA molecules selection pressure: The antigen-binding groove of HLA molecules
combine with a specific epitope of the HIV protein (For example, gap 120), inducing the
generation of helper T cells and cytotoxic T cells. In particular, CD8+ cytotoxic T lympho‐
cytes can kill infected CD4+ T lymphocyte in a direct manner, which can influence virus
replication, transmission, and AIDS progression. HLA molecules can employ different
epitopes for the same molecule, and stimulate generation of CTLs featuring different
quantities as well as specific properties, which has been confirmed in previous studies.
Therefore, this can better explain the differences in AIDS progress when individuals with
certain HLA phenotypes infected with HIV.
During viral infection, some viruses undergo degradation by cellular proteasome complex,
and the cytosolic antigenic peptides are carried into the ER. In this organelle, the peptides are
captured by HLA I molecules and then exposed on the cell surface, triggering the cytotoxic
activity of the circulating CD8+ T lymphocytes, as described previously. The HIV has devised
different ways to evade the immune response including a Nef-dependent mechanism that
downregulates the HLA I expression, thus avoiding the recognition of the infected cells by
CD8+ T lymphocytes (Fig2). Selectively, Nef alters the expression of HLA-A and -B by
recognition of a sequence (Y320SQAASS) present on the cytoplasmic tail of these HLA
molecules accelerating their endocytosis from the plasma membrane and blocking the
transport of newly synthesized MHC class I molecules to the cell surface. Nef maintains the
expression of HLA-C -G and -E unchanged, in order to inhibit the innate response of the natural
killer cells (NK). Furthermore, the gp41 protein of the viral envelope upregulates the synthesis
of IL-10 by monocytes; in turn, as mentioned before, this cytokine increases the expression of
HLA-G molecules to control immune response and facilitate infection.
Meanwhile, under the influence of CTLs that are induced by HLA, mutation of HIV can occur.
For example, TW10 peptide fragment (TAILQEQIAW) of gap protein in the HIV-1 virus, has
a specific mutation on the residue 242 in the individuals with HLA-B57 or B58 and can revert
to the wild type after the viruses detach from HLA-B57 or B58 molecules. This HIV mutation
can cause functional loss of specific CTL, and enable HIV to adapt to the HLA environment
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and overcome the immune responses, resulting in HIV susceptibility of specific HLA types as
well as a rapid progression of AIDS. Children of mothers with AIDS who have similar HLA
genes are at a higher risk of being infected with HIV, and they tend to progress to AIDS in a
shorter time. The possible reason for this is that the HIV of the mother might have adapted to
the HLA environment in the host, and the virus replication increases when HLA similarity is
high between the mother and child, which in turn makes it is easier for HIV to propagate and
lead to a faster progression of AIDS. But sometimes specific mutation of HIV can also lead to
a decrease in its virulence, enabling a reduced susceptibility of individuals towards HIV and
a slower progression of AIDS.
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Figure 2. The HIV has devised different ways to evade the immune response, including a Nef-dependent mechanism
that downregulates the HLA I expression, thus avoiding the recognition of the infected cells by CD8+ T lymphocytes.
Selectively, Nef alters the expression of HLA-A and -B by recognition of a sequence (Y320SQAASS) present on the cyto‐
plasmic tail of these HLA molecules accelerating their endocytosis from the plasma membrane and blocking the trans‐
port of newly synthesized MHC class I molecules to the cell surface. Nef maintains the expression of HLA-C, -G, and -E
unchanged, in order to inhibit the innate response of the natural killer cells (NK). NU: nucleus; GO: golgi apparatu
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